Comparing Neulasta vs Sargramostim
Neulasta | Sargramostim |
|
---|
Neulasta (pegfilgrastim) | Sargramostim |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Neulasta injection is a prescription medicine that may be given once every chemotherapy cycle to prevent febrile neutropenia in those people at high risk of it because of cancer treatments they are... View more |
Prescription only
Prescribed for Aplastic Anemia, Bone Marrow Transplantation, Bone Marrow Transplantation - Failure or Engraftment Delay, Bone Marrow Transplantation - Myeloid Reconstruction, Neutropenia Associated... View more |
Related suggestions Neutropenia Associated with Chemotherapy
Neutropenia Associated with Radiation
Popular comparisons
|
|||||||
More about Neulasta (pegfilgrastim) | More about Sargramostim | ||||||||
Ratings & Reviews | |||||||||
Neulasta has an average rating of 5.4 out of 10 from a total of 70 ratings on Drugs.com. 47% of reviewers reported a positive effect, while 42% reported a negative effect. |
Be the first to share your experience with this drug. |
||||||||
Drug Class | |||||||||
Side Effects | |||||||||
See also: Neulasta side effects in more detail. |
See also: sargramostim side effects in more detail. |
||||||||
Generic Availability | |||||||||
N/A |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all Neulasta prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Form(s) Available | |||||||||
|
N/A |
||||||||
Brand Names | |||||||||
Other pegfilgrastim brands include: Fulphila, Fylnetra, Nyvepria, Stimufend, Udenyca, Ziextenzo | Leukine | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||
80 hours |
2.8 hours |
||||||||
CSA Schedule ** View glossary of terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 172 drugs are known to interact with Neulasta:
|
A total of 168 drugs are known to interact with sargramostim:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
January 31, 2002 |
N/A |
||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.